Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Am J Surg Pathol. 2019 Apr;43(4):466–474. doi: 10.1097/PAS.0000000000001224

Table 3.

Multivariate analysis of OS, DFS and PFS in IECC cohort with respect to covariates age, FIGO stage, grade, tumor size and Silva pattern in the entire cohort, HPVA only and NHPVA groups.

Covariate OS DFS PFS
p value HR CI p value HR CI p value HR CI
All (HPVA and NHPVA)
HPV status 0.060 0.14 0.03–0.95 0.064 0.14 0.02–1.02 0.81 1.3 0.14–11
Age 0.95 1 0.96–1.05 0.77 1.01 0.96–1.05 0.97 1 0.96–1.04
Stage (I/II vs III/IV) 0.056 7.73 1.32–33.8 0.044 8.43 1.47–37.3 0.65 1.45 0.3–7.09
Grade (1 vs 2 vs 3) 0.34 3.42, 3.51 0.21–520, 0.27–494 0.39 2.55, 2.98 0.16–393, 0.23–416 0.067 0.37 0.13–1.08
Size 0.10 1.03 0.99–1.07 0.067 1.04 1–1.08 0.48 0.99 0.96–1.02
Silva pattern (A/ B vs C) 0.09 3.5 0.4–458 0.18 2.29 0.24–304 - - -
HPVA only
Age 0.83 1.01 0.96–1.05 0.63 1.02 0.96–1.06 0.96 1 0.96–1.04
Stage (I/II vs III/IV) 0.072 6.98 1.17–30 0.056 7.48 1.31–32 0.73 1.32 0.27–6.4
Grade (1 vs 2 vs 3) 0.95 0.33, 0.3 0–64, 0–65 0.99 0.32, 0.33 0–63, 0–74 0.072 0.38 0.13–1.1
Size 0.19 1.03 0.99–1.07 0.10 1.03 0.99–1.08 0.44 0.99 0.96–1.02
Silva pattern (A/B vs C) 0.086 4.14 - 0.18 2.58 - - - -
NHPVA only
Age 0.032 1.06 1–1.1 0.052 1.09 1–1.18 0.51 1.02 0.96–1.1
Stage (I/II vs III/IV) 0.022 8×109 - 0.0044 5×1022 - 1 9×108 -
Grade (1 vs 2 vs 3) 0.54 0.35, 1.17 0.02–5.5, 0.18–7.4 0.098 0, 0.74 0.09–6.06 0.44 0.4 0.04–4.03
Size 0.0022 1.1 1.01–1.19 0.0035 1.1 1.01–1.2 0.27 1.04 0.97–1.1
Silva pattern (A/B vs C) - - - - - - - - -